Edward Miller
General Practice · Jefferson, NCNPI 1538194410
Payments from drug & device makers
Across 100 payments — averaging $12.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$203
- Johnson & Johnson$120
- Amgen$106
- GSK$105
- Pfizer$101
- AbbVie$93
- plus $480 from 13 others
What the payments were for
- Food & beverage$1,206100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $203 |
| Johnson & Johnson | 18 | $120 |
| Amgen | 6 | $106 |
| GSK | 7 | $105 |
| Pfizer | 7 | $101 |
| AbbVie(2 entities) | 7 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $66 |
| Sanofi-aventis U.S. LLC | 5 | $66 |
| Lilly USA, LLC | 5 | $63 |
| AstraZeneca | 5 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $42 |
| Mylan Specialty L.p. | 2 | $32 |
| Astellas Pharma US Inc | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Ironshore Pharmaceuticals Inc. | 2 | $24 |
| Merck | 2 | $23 |
| Exact Sciences | 1 | $18 |
| Novartis | 1 | $18 |
| Boehringer Ingelheim | 1 | $13 |
How this compares
$1,209 in reported general payments places this provider in the 80th percentile of 2,924 general practice providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 69 | $60,254 |
| MyrbetriqMirabegron | 25 | $11,369 |
| JardianceEmpagliflozin | 17 | $10,342 |
| Rosuvastatin Calcium | 183 | $2,618 |
| Metoprolol Succinate | 83 | $1,483 |
| Losartan Potassium | 124 | $1,455 |
| Lidocaine | 11 | $1,443 |
| Ezetimibe | 38 | $1,182 |
| Pantoprazole Sodium | 63 | $1,032 |
| Donepezil Hcl | 37 | $904 |
| Metformin Hcl | 97 | $868 |
| Gabapentin | 80 | $838 |
| Omeprazole | 60 | $828 |
| Mirtazapine | 19 | $796 |
| Nebivolol Hcl | 14 | $705 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $101 | $60,25469 claims |
| Astellas Pharma US IncMyrbetriq | $28 | $11,36925 claims |
| Boehringer IngelheimJardiance | $13 | $10,34217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,924 general practice providers in North Carolina.
Other general practice in Jefferson
- Matthew MillerCharlotte$937K
- James BarberDurham$768K
- Robert LoweCharlotte$615K
- Howard JamesSanford$483K
- Clifton CameronFayetteville$404K
- Michael HarrisonRaleigh$249K
- Ronnie DavidsonMooresville$151K
- Leo HaydtHolly Springs$119K
- Andrew KellyGreensboro$115K
- Mark HymanGreensboro$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.